EQUITY Equity (Tables)
|
9 Months Ended |
Sep. 30, 2020 |
|---|
| Equity [Abstract] |
|
| Schedule of Accumulated Other Comprehensive Income (Loss) |
The following table presents changes in the components of AOCI, net of taxes, for the nine months ended September 30, 2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on Cash Flow Hedge |
|
Foreign Currency Items |
|
Total |
|
(in thousands) |
| Balance at December 31, 2019 |
$ |
— |
|
|
$ |
(145,713) |
|
|
$ |
(145,713) |
|
Other comprehensive loss before reclassifications |
(38,845) |
|
|
(40,866) |
|
|
(79,711) |
|
| Amount reclassified from AOCI |
3,207 |
|
|
— |
|
|
3,207 |
|
| Net other comprehensive loss |
(35,638) |
|
|
(40,866) |
|
|
(76,504) |
|
| Balance at September 30, 2020 |
$ |
(35,638) |
|
|
$ |
(186,579) |
|
|
$ |
(222,217) |
|
|
| Schedule of Weighted Average Number of Shares |
The following table sets forth the computation of weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
|
2020 |
|
2019 |
|
2020 |
|
2019 |
|
(in thousands) |
| Weighted average common shares—basic |
212,593,719 |
|
|
210,621,971 |
|
|
211,781,620 |
|
|
209,849,058 |
|
| Effect of dilutive securities: |
|
|
|
|
|
|
|
| Stock options and restricted stock |
— |
|
|
8,335,405 |
|
|
— |
|
|
8,249,695 |
|
| Convertible senior notes |
— |
|
|
— |
|
|
— |
|
|
386,741 |
|
| Weighted average common shares—diluted |
212,593,719 |
|
|
218,957,376 |
|
|
211,781,620 |
|
|
218,485,494 |
|
|
| Potentially Dilutive Securities Excluded From Diluted Net Income (Loss) Per Common Share |
The following table shows securities excluded from the calculation of diluted net income (loss) per common share because such securities are anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
|
2020 |
|
2019 |
|
2020 |
|
2019 |
| Options to purchase shares of common stock |
9,874,376 |
|
|
311,500 |
|
|
9,874,376 |
|
|
486,849 |
|
| Restricted stock and deferred stock—unvested |
3,713,249 |
|
|
959,089 |
|
|
3,713,249 |
|
|
959,089 |
|
|
|
|
|
|
|
|
|
| Conversion shares related to the convertible senior notes |
11,864,035 |
|
|
8,085,275 |
|
|
10,729,717 |
|
|
8,085,275 |
|
| Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding |
25,451,660 |
|
|
9,355,864 |
|
|
24,317,342 |
|
|
9,531,213 |
|
|